ArticleJournal of clinical laboratory analysis2020

MicroRNA-497/fibroblast growth factor-23 axis, a predictive indictor for decreased major adverse cardiac and cerebral event risk in end-stage renal disease patients who underwent continuous ambulatory peritoneal dialysis.

Dianjun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.